Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COSMIC-HF: Omecamtiv Mecarbil in Heart Failure
NCT01786512Phase 2Completed
- Sponsor
- Cytokinetics
- Start
- Feb 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of omecamtiv mecarbil in chronic heart failure (CHF), left ventricular systolic dysfunction (LVSD), sponsored by Cytokinetics. Started Feb 2013; status: completed.
02
Drugs
omecamtiv mecarbil
03
Conditions
chronic heart failure (CHF)left ventricular systolic dysfunction (LVSD)
Beyond the preview
Go deeper on NCT01786512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01786512.